Registry for anesthesia during transcatheter aortic valve implantation
Official title: Anesthesia for Catheter Aortic Valve ImplantATIOn Registry
Run by Deutsches Herzzentrum Muenchen · NCT01390675 · Data updated 2026-11-12
This study is looking at how anesthesia is managed during heart valve procedures for high-risk patients to help improve care in the future.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Deutsches Herzzentrum Muenchen Academic / other |
| Locations | 1 site (Munich, Bavaria) |
| Status | Recruiting |
| Started | June 2011 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | August 7, 2024 |
| Trial ID | NCT01390675 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are patients undergoing transcatheter aortic valve implantation (TAVI).
✕Probably not a fit
Patients who refuse to participate will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry aims to evaluate the intraoperative anesthesiologic characteristics faced by cardiac anesthesiologists during transcatheter aortic valve implantation (TAVI) procedures. It focuses on high-risk patients who are typically considered inoperable and seeks to gather data on anesthesia management and outcomes. By documenting these experiences, the study aims to improve understanding and practices in anesthesia for TAVI. The study will include patients undergoing TAVI at a specialized cardiac center in Munich.
Why it matters
Potential benefit: If successful, this study could enhance anesthesia practices and improve patient outcomes during TAVI procedures.
How similar studies have gone: While this study focuses on a specific observational registry, similar studies in anesthesia for cardiac procedures have shown promising results in improving patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Patients undergoing transcatheter aortic valve implantation (TAVI) Exclusion Criteria: \- Refusal by patient
Where it's running
-
Deutsches Herzzentrum München, Department of Anaesthesiology, Technische Universität München
Munich, Bavaria, Germany Recruiting
Study contacts
- Principal investigator: Patrick N Mayr, M.D. — Deutsches Herzzentrum München, Technische Universität München
- Study coordinator: Patrick N Mayr, M.D.
- Email: mayrp@dhm.mhn.de
- Phone: +49 89 1218
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.